Meihua International Medical Technologies Co., Ltd.(MHUA)Earnings, Financials & Key Ratios

MHUA•NASDAQ

$7.61

$2M mkt cap·0.2× P/E·Price updated Apr 24, 2026

SectorHealthcare IndustryMedical Instruments Sub-IndustryDrug delivery and infusion consumables

AboutMeihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Show more

Revenue$97M-0.2%
EBITDA$15M-1.7%
Net Income$11M-6.7%
EPS (Diluted)40.00-18.4%
Gross Margin34.36%+0.8%
EBITDA Margin15.36%-1.5%
Operating Margin14.77%-2.3%
Net Margin11.19%-6.5%
ROE7.09%-12.9%
ROIC7.45%-13.4%
Debt/Equity0.05+0.1%
Interest Coverage9.50-83.8%

Technical→

MHUA Key Insights

Meihua International Medical Technologies Co., Ltd. (MHUA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 14.1%
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak momentum: RS Rating 5 (bottom 5%)
✗Shares diluted 14.3% in last year
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

MHUA Price & Volume

Meihua International Medical Technologies Co., Ltd. (MHUA) stock price & volume — 10-year historical chart

Loading chart...

MHUA Growth Metrics

Meihua International Medical Technologies Co., Ltd. (MHUA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years4.01%

3 Years-2.34%

TTM-11.3%

Profit CAGR

10 Years-

5 Years-6.81%

3 Years-19.71%

TTM-26.27%

EPS CAGR

10 Years-

5 Years-8.97%

3 Years-23.4%

TTM-44.54%

Return on Capital

10 Years24.07%

5 Years17.63%

3 Years9.45%

Last Year9.36%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
CODACoda Octopus Group, Inc.Direct Competitor	134.35M	11.92	32.22	30.75%	14.78%	7.17%	0.01
ATECAlphatec Holdings, Inc.Direct Competitor	1.06B	6.99	-7.28	24.95%	-21.07%	-141.88%	17.21
XTLBXTL Biopharmaceuticals Ltd.Direct Competitor	357.58K	3.25	-0.34		-227.72%	-25.53%	0.03
MMSIMerit Medical Systems, Inc.Product Competitor	3.68B	61.63	28.93	11.66%	9.03%	8.95%	0.57
NVCRNovoCure LimitedProduct Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
INVAInnoviva, Inc.Product Competitor	1.91B	22.52	6.82	18.52%	118.91%	46.47%	0.23
ANGOAngioDynamics, Inc.Product Competitor	459.4M	11.05	-13.31	-3.76%	-9.02%	-15.71%
MDTMedtronic plcSupply Chain	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59

Compare MHUA vs Peers

Meihua International Medical Technologies Co., Ltd. (MHUA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CODA

Most directly comparable listed peer for MHUA.

Scale Benchmark

vs SYK

Larger-name benchmark to compare MHUA against a more recognizable public peer.

Peer Set

Compare Top 5

vs CODA, ATEC, XTLB, MMSI

MHUA Income Statement

Meihua International Medical Technologies Co., Ltd. (MHUA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Sales/Revenue	75.71M	79.63M	89.06M	104.04M	103.35M	97.1M	96.91M	183.8M
Revenue Growth %	-	5.18%	11.85%	16.82%	-0.66%	-6.05%	-0.19%	-11.3%
Cost of Goods Sold	43.82M	47.42M	51.9M	64.23M	65.25M	64M	63.61M	122.05M
COGS % of Revenue	57.88%	59.55%	58.28%	61.74%	63.14%	65.92%	65.64%	-
Gross Profit	31.89M▲ 0%	32.21M▲ 1.0%	37.16M▲ 15.4%	39.81M▲ 7.1%	38.1M▼ 4.3%	33.09M▼ 13.1%	33.3M▲ 0.6%	61.75M▲ 0%
Gross Margin %	42.12%	40.45%	41.72%	38.26%	36.86%	34.08%	34.36%	33.6%
Gross Profit Growth %	-	1.01%	15.37%	7.12%	-4.29%	-13.13%	0.62%	-
Operating Expenses	13.1M	12.82M	13.69M	14.5M	22.54M	18.42M	18.99M	38.64M
OpEx % of Revenue	17.3%	16.1%	15.38%	13.94%	21.81%	18.97%	19.59%	-
Selling, General & Admin	9.85M	8.68M	10.34M	11.78M	18.68M	12.97M	13.52M	32.22M
SG&A % of Revenue	13.01%	10.9%	11.61%	11.32%	18.07%	13.35%	13.95%	-
Research & Development	2.87M	3.21M	2.49M	2.73M	2.96M	2.75M	3.46M	6.08M
R&D % of Revenue	3.78%	4.04%	2.8%	2.62%	2.87%	2.84%	3.57%	-
Other Operating Expenses	0	926.2K	864.79K	0	898.66K	2.7M	2.01M	340.9K
Operating Income	19.18M▲ 0%	19.39M▲ 1.1%	23.47M▲ 21.0%	26.26M▲ 11.9%	10.8M▼ 58.9%	14.67M▲ 35.9%	14.31M▼ 2.5%	23.13M▲ 0%
Operating Margin %	25.33%	24.35%	26.35%	25.24%	10.45%	15.11%	14.77%	12.58%
Operating Income Growth %	-	1.1%	21.04%	11.91%	-58.87%	35.85%	-2.47%	-
EBITDA	19.74M	19.9M	23.99M	26.88M	11.37M	15.15M	14.88M	24.15M
EBITDA Margin %	26.08%	24.99%	26.94%	25.84%	11%	15.6%	15.36%	13.14%
EBITDA Growth %	-	0.77%	20.57%	12.06%	-57.72%	33.26%	-1.74%	-32.11%
D&A (Non-Cash Add-back)	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K	1.02M
EBIT	19.18M	19.35M	23.87M	26.41M	11.09M	15.3M	15.13M	23.83M
Net Interest Income	0	-48.95K	-100.58K	-156.89K	-130.94K	622.66K	-492.3K	2.73M
Interest Income	77.42K	48.84K	36.58K	23.86K	63.73K	873.44K	1.01M	3.48M
Interest Expense	0	97.79K	137.16K	180.74K	194.67K	250.78K	1.51M	747.74K
Other Income/Expense	-465.98K	-137.69K	267.35K	-32.91K	89.28K	373.84K	-685.78K	252.69K
Pretax Income	18.71M▲ 0%	19.25M▲ 2.9%	23.73M▲ 23.3%	26.23M▲ 10.5%	10.89M▼ 58.5%	15.05M▲ 38.2%	13.63M▼ 9.5%	23.38M▲ 0%
Pretax Margin %	24.72%	24.18%	26.65%	25.21%	10.54%	15.5%	14.06%	12.72%
Income Tax	3.23M	3.82M	4.69M	5.28M	4.71M	3.46M	2.79M	4.84M
Effective Tax Rate %	17.28%	19.84%	19.75%	20.13%	43.28%	22.98%	20.47%	20.7%
Net Income	15.48M▲ 0%	15.43M▼ 0.3%	19.05M▲ 23.4%	20.95M▲ 10.0%	6.24M▼ 70.2%	11.63M▲ 86.2%	10.84M▼ 6.7%	18.55M▲ 0%
Net Margin %	20.44%	19.38%	21.38%	20.14%	6.04%	11.97%	11.19%	10.09%
Net Income Growth %	-	-0.3%	23.42%	10%	-70.2%	86.22%	-6.73%	-26.27%
Net Income (Continuing)	15.48M	15.43M	19.05M	20.95M	6.18M	11.59M	10.84M	18.54M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	556.14K	505.98K	0	0
EPS (Diluted)	77.00▲ 0%	64.00▼ 16.9%	79.00▲ 23.4%	89.00▲ 12.7%	27.00▼ 69.7%	49.00▲ 81.5%	40.00▼ 18.4%	58.15▲ 0%
EPS Growth %	-	-16.88%	23.44%	12.66%	-69.66%	81.48%	-18.37%	-44.54%
EPS (Basic)	77.00	64.00	79.00	89.00	27.00	49.00	40.00	-
Diluted Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K	319.05K
Basic Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K	319.05K
Dividend Payout Ratio	-	-	-	-	-	-	-	-

MHUA Balance Sheet

Meihua International Medical Technologies Co., Ltd. (MHUA) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Total Current Assets	49.97M	52.58M	67.57M	97.28M	135.32M	132.24M	143.44M	146.34M
Cash & Short-Term Investments	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M	15.55M
Cash Only	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M	15.55M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	32.98M	35.41M	58.56M	86.48M	91.03M	99.48M	115M	117.67M
Days Sales Outstanding	159	162.33	239.98	303.41	321.51	373.95	433.13	218.14
Inventory	1.84M	1.02M	1.33M	1.25M	1.12M	1.62M	1.41M	1.1M
Days Inventory Outstanding	15.36	7.89	9.33	7.11	6.28	9.22	8.09	3.9
Other Current Assets	344.84K	107.94K	496.61K	1.39M	16.43M	14.23M	1.48M	12.03M
Total Non-Current Assets	12.45M	20.63M	38.48M	39.58M	28.26M	39.68M	42.8M	44.24M
Property, Plant & Equipment	3.7M	3.4M	20.13M	7.48M	8.76M	8.84M	7.89M	7.78M
Fixed Asset Turnover	20.46x	23.41x	4.42x	13.91x	11.80x	10.99x	12.29x	22.49x
Goodwill	0	0	0	-17.26M	0	0	0	0
Intangible Assets	600.78K	16.37M	17.43M	17.82M	497.6K	3.92M	443.04K	443.65K
Long-Term Investments	872.66K	861.85K	919.54K	941.53K	6.67M	6.13M	22.39M	60.04M
Other Non-Current Assets	7.27M	15.8M	29.89M	30.6M	12.33M	20.42M	11.09M	64.61M
Total Assets	62.42M▲ 0%	73.2M▲ 17.3%	106.05M▲ 44.9%	136.86M▲ 29.1%	163.58M▲ 19.5%	171.92M▲ 5.1%	186.24M▲ 8.3%	190.58M▲ 0%
Asset Turnover	1.21x	1.09x	0.84x	0.76x	0.63x	0.56x	0.52x	1.01x
Asset Growth %	-	17.28%	44.87%	29.05%	19.52%	5.1%	8.33%	29.98%
Total Current Liabilities	17.96M	13.55M	21.31M	29.09M	24.17M	25.07M	27.26M	25.64M
Accounts Payable	13.73M	9.36M	15.64M	20.98M	16.1M	15.82M	15.48M	11.35M
Days Payables Outstanding	114.33	72.05	109.98	119.22	90.04	90.23	88.8	43.74
Short-Term Debt	2.04M	2.59M	3.22M	5.18M	6.09M	7.32M	7.95M	11.45M
Deferred Revenue (Current)	0	0	1.75M	0	0	0	0	0
Other Current Liabilities	956.04K	851.17K	-494.98K	0	0	409.89K	1.33M	1.35M
Current Ratio	2.78x	3.88x	3.17x	3.34x	5.60x	5.27x	5.26x	5.26x
Quick Ratio	2.68x	3.81x	3.11x	3.30x	5.55x	5.21x	5.21x	5.21x
Cash Conversion Cycle	60.03	98.17	139.33	191.29	237.74	292.95	352.42	178.3
Total Non-Current Liabilities	0	0	0	0	724.93K	4.59K	0	0
Long-Term Debt	0	0	0	0	724.93K	0	0	0
Capital Lease Obligations	0	0	0	0	0	4.59K	0	4.59K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0
Total Liabilities	17.96M	13.55M	21.31M	30.05M	24.9M	25.08M	27.26M	25.64M
Total Debt	2.04M	2.59M	3.22M	5.18M	6.81M	7.33M	7.95M	11.45M
Net Debt	-12.77M	-13.45M	-3.97M	-2.97M	-19.92M	-9.6M	-8.01M	-4.1M
Debt / Equity	0.05x	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x	0.05x
Debt / EBITDA	0.10x	0.13x	0.13x	0.19x	0.60x	0.48x	0.53x	0.47x
Net Debt / EBITDA	-0.65x	-0.68x	-0.17x	-0.11x	-1.75x	-0.63x	-0.54x	-0.54x
Interest Coverage	-	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x	31.87x
Total Equity	44.46M▲ 0%	59.66M▲ 34.2%	84.74M▲ 42.0%	106.81M▲ 26.1%	138.68M▲ 29.8%	146.84M▲ 5.9%	158.98M▲ 8.3%	164.95M▲ 0%
Equity Growth %	-	34.18%	42.04%	26.05%	29.84%	5.88%	8.27%	31.73%
Book Value per Share	222.31	247.13	351.02	452.59	592.36	613.36	580.80	517.00
Total Shareholders' Equity	44.46M	59.66M	84.74M	106.81M	138.12M	146.33M	158.98M	164.95M
Common Stock	10K	10K	10K	10K	11.97K	11.97K	15.95K	15.95K
Retained Earnings	37.33M	52.76M	56.63M	76.62M	83.33M	94.64M	105.23M	124.61M
Treasury Stock	0	0	0	0	0	0	-200K	-200K
Accumulated OCI	-2.59M	-2.83M	18.38M	20.47M	11.81M	8.72M	4.71M	-8.7M
Minority Interest	0	0	0	0	556.14K	505.98K	0	0

MHUA Cash Flow Statement

Meihua International Medical Technologies Co., Ltd. (MHUA) cash flow — operating, investing & free cash flow history

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Cash from Operations	11.82M	9.31M	5.33M	-54.66K	-9.16M	2.28M	14.64M	14.64M
Operating CF Margin %	15.61%	11.69%	5.98%	-0.05%	-8.87%	2.34%	15.1%	-
Operating CF Growth %	-	-21.23%	-42.78%	-101.03%	-16662.78%	124.84%	543.16%	-1189.6%
Net Income	15.48M	15.43M	19.05M	19.99M	6.18M	11.59M	10.84M	18.55M
Depreciation & Amortization	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K	1.02M
Stock-Based Compensation	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	-370.48K	-642.63K	0
Other Non-Cash Items	6.71M	-9.53K	2.85K	15.28K	4.51M	2.18M	3.9M	-5.99M
Working Capital Changes	-10.94M	-6.62M	-14.25M	-20.68M	-20.41M	-11.6M	-27.97K	-11.05M
Change in Receivables	-11.09M	-4.71M	-13.64M	-20.07M	-7.12M	-14.02M	-3.21M	-13.91M
Change in Inventory	-170.6K	802.61K	-219.79K	105.12K	35.03K	-528.63K	165.76K	575.72K
Change in Payables	0	-4.23M	5.34M	4.91M	-3.37M	185.9K	932.49K	0
Cash from Investing	-7.57M	-8.9M	-16.09M	-833.82K	-8.62M	-12.46M	-20.42M	-16.84M
Capital Expenditures	-12.3K	-8.95M	-16.12M	-850.23K	-2.7M	-1.18M	-133.55K	-324.57K
CapEx % of Revenue	0.02%	11.24%	18.1%	0.82%	2.61%	1.22%	0.14%	-
Acquisitions	0	50.6K	25.2K	16.41K	658.46K	0	-89.72K	0
Investments	-	-	-	-	-	-	-	-
Other Investing	-7.56M	0	0	0	23.15K	-11.63M	-15.9M	-16.51M
Cash from Financing	-4.2M	923.77K	1.71M	1.86M	37.25M	706.13K	6.21M	12.82M
Debt Issued (Net)	0	579.03K	434.52K	1.86M	2.08M	706.13K	6.41M	6.62M
Equity Issued (Net)	0	0	1000K	0	1000K	0	-200K	-200K
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	-200K	-200K
Other Financing	-4.2M	344.74K	0	0	635.31K	0	0	6.4M
Net Change in Cash	-794.34K▲ 0%	1.23M▲ 254.5%	-8.84M▼ 820.6%	961.94K▲ 110.9%	18.59M▲ 1832.3%	-9.81M▼ 152.8%	362.07K▲ 103.7%	-71.78K▲ 0%
Free Cash Flow	11.8M▲ 0%	356.12K▼ 97.0%	-10.79M▼ 3130.9%	-904.89K▲ 91.6%	-11.86M▼ 1210.8%	-2.41M▲ 79.7%	14.5M▲ 701.6%	12.11M▲ 0%
FCF Margin %	15.59%	0.45%	-12.12%	-0.87%	-11.48%	-2.48%	14.97%	6.59%
FCF Growth %	-	-96.98%	-3130.93%	91.62%	-1210.85%	79.68%	701.59%	157.8%
FCF per Share	59.02	1.48	-44.71	-3.83	-50.67	-10.07	52.99	52.99
FCF Conversion (FCF/Net Income)	0.76x	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x	0.65x
Interest Paid	0	97.79K	137.16K	180.74K	194.67K	250.78K	247.62K	129.86K
Taxes Paid	0	3.9M	4.36M	5.04M	5.7M	3.58M	3.66M	0

MHUA Key Ratios

Meihua International Medical Technologies Co., Ltd. (MHUA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2019	2020	2021	2022	2023	2024	TTM
Return on Equity (ROE)	29.64%	26.38%	21.87%	5.09%	8.14%	7.09%	11.25%
Return on Invested Capital (ROIC)	37.33%	27.72%	21.34%	7.28%	8.6%	7.45%	7.45%
Gross Margin	40.45%	41.72%	38.26%	36.86%	34.08%	34.36%	33.6%
Net Margin	19.38%	21.38%	20.14%	6.04%	11.97%	11.19%	10.09%
Debt / Equity	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x	0.05x
Interest Coverage	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x	31.87x
FCF Conversion	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x	0.65x
Revenue Growth	5.18%	11.85%	16.82%	-0.66%	-6.05%	-0.19%	-11.3%

MHUA Frequently Asked Questions

Meihua International Medical Technologies Co., Ltd. (MHUA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.

Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.

Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).

Dividend & Returns

Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More MHUA

Meihua International Medical Technologies Co., Ltd. (MHUA) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Meihua International Medical Technologies Co., Ltd.(MHUA)Earnings, Financials & Key Ratios

MHUA Key Insights

✓Strengths

✗Weaknesses

MHUA Price & Volume

MHUA Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

MHUA Peer Comparison

Compare MHUA vs Peers

vs CODA

vs SYK

Compare Top 5

MHUA Income Statement

MHUA Balance Sheet

MHUA Cash Flow Statement

MHUA Key Ratios

MHUA Frequently Asked Questions

Explore More MHUA

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation